Effective Provider-patient Communication of a Rare Disease Diagnosis: A Qualitative Study of People Diagnosed with Schwannomatosis
Overview
Nursing
Affiliations
Objective: To understand diagnostic communication preferences of patients with schwannomatosis, a rare disease.
Methods: Eighteen adults with schwannomatosis from across the United States participated in semi-structured phone interviews about their diagnostic experiences. Interview transcripts were inductively coded using thematic analysis.
Results: We identified three elements of effective diagnostic communication: education (particularly about etiology, prognosis, and treatment options); psychological support (to cope with the new diagnosis and any prior diagnostic harms); and efforts to develop therapeutic alliance (i.e. feelings of collaboration, trust, and social-emotional rapport). Poor communication was characterized by inadequate or jargon-heavy explanations, perceived disinterest in or disbelief of symptoms, and lack of partnership. Effective communication helped people feel informed and cope with their condition; poor communication could cause significant psychological distress.
Conclusions: During diagnosis, patients need education and psychosocial support; the presence of therapeutic alliance between clinicians and patients facilitates this assistance. Diagnostic communication that includes these elements helps patients proactively engage in healthcare decision-making and connect with appropriate treatments.
Practice Implications: When disclosing a rare disease diagnosis, clinicians should meaningfully educate patients about the disorder and acknowledge diagnosis-related psychosocial stressors. Approaching diagnosis empathetically and collaboratively helps foster therapeutic alliance. Referrals for psychological and genetic counseling are often warranted.
Al-Attar M, Butterworth S, McKay L Orphanet J Rare Dis. 2024; 19(1):172.
PMID: 38641814 PMC: 11031885. DOI: 10.1186/s13023-024-03143-8.
Devisetti L Orphanet J Rare Dis. 2024; 19(1):37.
PMID: 38403651 PMC: 10895854. DOI: 10.1186/s13023-024-03050-y.
Spencer-Tansley R, Meade N, Ali F, Simpson A, Hunter A BMC Health Serv Res. 2022; 22(1):648.
PMID: 35568910 PMC: 9107210. DOI: 10.1186/s12913-022-08060-9.
Current Status of Genetic Counselling for Rare Diseases in Spain.
Alvaro-Sanchez S, Abreu-Rodriguez I, Abuli A, Serra-Juhe C, Garrido-Navas M Diagnostics (Basel). 2021; 11(12).
PMID: 34943558 PMC: 8700506. DOI: 10.3390/diagnostics11122320.